Reading Tip!
>To get to the fulltext easy, use the library proxy bookmarklet or activate our Pubmed url for the Get it! button!
Categories
- Acta Derm Venereol (8)
- Allergy (2)
- Am J Dermatopathol (1)
- Am J Kidney Dis (1)
- Anal Bioanal Chem (1)
- Anal Chem (1)
- Ann Med (1)
- Arch Dermatol (3)
- Arch Phys Med Rehabil (1)
- Arthritis Res Ther (1)
- Arthritis Rheum (1)
- Australas J Dermatol (1)
- BMC Proc (1)
- Br J Dermatol (50)
- Cell Tissue Res (1)
- Clin Exp Dermatol (2)
- Contact Dermatitis (51)
- Dermatol Clin (3)
- Dermatol Res Pract (1)
- Dermatol Surg (1)
- Disabil Rehabil (1)
- Discov Med (2)
- Drugs Aging (2)
- Eur J Dermatol (10)
- Eur J Immunol (1)
- Exp Dermatol (4)
- Front Immunol (1)
- Genes Immun (1)
- Genet Test Mol Biomarkers (1)
- Hum Mol Genet (1)
- Hum Mutat (1)
- Hum Pathol (1)
- Infect Immun (1)
- Inflamm Bowel Dis (1)
- Int J Dermatol (1)
- Int J Med Microbiol (1)
- Invest Ophthalmol Vis Sci (1)
- J Allergy Clin Immunol (3)
- J Am Acad Dermatol (10)
- J Clin Invest (1)
- J Clin Virol (1)
- J Cutan Pathol (3)
- J Dermatol Sci (2)
- J Dtsch Dermatol Ges (4)
- J Eur Acad Dermatol Venereol (9)
- J Hand Ther (1)
- J Immunol (1)
- J Invest Dermatol (20)
- J Med Genet (1)
- J Strength Cond Res (2)
- JAMA Dermatol (4)
- JNMA J Nepal Med Assoc (1)
- Lab Chip (1)
- Methods Mol Biol (1)
- Mol Vis (1)
- N Engl J Med (1)
- Ned Tijdschr Geneeskd (13)
- Ned Tijdschr Tandheelkd (1)
- Neth J Med (1)
- Occup Environ Med (1)
- Opt Lett (1)
- PLoS One (2)
- Qual Health Res (1)
- Regul Toxicol Pharmacol (2)
- Report (1)
- Sci Transl Med (1)
- Skin Res Technol (2)
- Trials (1)
Archives
- May 2022
- April 2022
- March 2022
- February 2022
- January 2022
- December 2021
- November 2021
- October 2021
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- January 2021
- December 2020
- November 2020
- October 2020
- September 2020
- August 2020
- July 2020
- June 2020
- May 2020
- April 2020
- March 2020
- February 2020
- December 2019
- October 2019
- September 2019
- July 2019
- May 2019
- February 2019
- January 2019
- December 2018
- November 2018
- October 2018
- August 2018
- April 2018
- February 2018
- January 2018
- July 2017
- June 2017
- March 2017
- February 2017
- August 2016
- July 2016
- April 2016
- March 2016
- February 2016
- January 2016
- December 2015
- November 2015
- October 2015
- September 2015
- August 2015
- June 2015
- May 2015
- April 2015
- March 2015
- February 2015
- January 2015
- December 2014
- November 2014
- October 2014
- September 2014
- August 2014
- July 2014
- June 2014
- April 2014
- March 2014
- February 2014
- November 2013
- September 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- August 2012
- July 2012
- June 2012
Contributors
Meta
Monthly Archives: June 2015
Drug survival for methotrexate in a daily practice cohort of adult patients with severe atopic dermatitis.
Related Articles
Drug survival for methotrexate in a daily practice cohort of adult patients with severe atopic dermatitis.
Br J Dermatol. 2015 Jun 25;
Authors: Politiek K, Schaft JV, Coenraads PJ, de Bruin-Weller MS,… Continue reading
Posted in Br J Dermatol
Comments Off on Drug survival for methotrexate in a daily practice cohort of adult patients with severe atopic dermatitis.
Patch test results with fragrance markers of the baseline series?-?analysis of the European Surveillance System on Contact Allergies (ESSCA) network 2009-2012.
Related Articles |
Patch test results with fragrance markers of the baseline series - analysis of the European Surveillance System on Contact Allergies (ESSCA) network 2009-2012.
Contact Dermatitis. 2015 Jun 16;
Authors: Frosch PJ, Duus Johansen J, Schuttelaar ML, Silvestre JF, Sánchez-Pérez J, Weisshaar E, Uter W, (on behalf of the ESSCA network)
Abstract
BACKGROUND: Contact allergy to fragrances is common, and impairs quality of life, particularly in young women.
OBJECTIVE: To provide current results on the prevalences of sensitization to fragrance allergens used as markers in the baseline series of most European countries.
METHODS: Data of patients consecutively patch tested between 2009 and 2012 in 12 European countries with fragrance allergens contained in the baseline series were collected by the European Surveillance System on Contact Allergies network and descriptively analysed. Four departments used the TRUE Test® system.
RESULTS: The ‘basic markers’ were tested on 51 477 [fragrance mix II (FM II)] to 57 123 [Myroxylon pereirae, balsam of Peru] patients, and yielded positive reactions as follows: fragrance mix I 6.9%, Myroxylon pereirae 5.4%, FM II 3.8%, colophonium 2.6%, and hydroxyisohexyl 3-cyclohexene carboxaldehyde 1.7%, with some regional differences. Prevalences with TRUE Test® allergens were lower. Additional fragrances were tested on 3643 (trimethylbenzenepropanol) to 14 071 (oil of turpentine) patients, and yielded between 2.6% (Cananga odorata) and 0.7% (trimethylbenzenepropanol) positive reactions.
CONCLUSIONS: Contact allergy to fragrances is common throughout Europe, with regional variation probably being explained by patch test technique, and differences in exposure and referral patterns. The current basic markers of fragrance sensitivity in the baseline series should be supplemented with additional fragrance allergens.
PMID: 26080686 [PubMed – as supplied by publisher]
Posted in Contact Dermatitis
Comments Off on Patch test results with fragrance markers of the baseline series?-?analysis of the European Surveillance System on Contact Allergies (ESSCA) network 2009-2012.
Allergic contact dermatitis presenting as severe and persistent blepharoconjunctivitis and centrofacial oedema after dyeing of eyelashes.
Related Articles
Allergic contact dermatitis presenting as severe and persistent blepharoconjunctivitis and centrofacial oedema after dyeing of eyelashes.
Contact Dermatitis. 2014 Nov;71(5):304-6
Authors: Vogel TA, C… Continue reading
Posted in Contact Dermatitis
Comments Off on Allergic contact dermatitis presenting as severe and persistent blepharoconjunctivitis and centrofacial oedema after dyeing of eyelashes.
Epidermolysis Bullosa Pruriginosa Excoriée: A Deceptive Pruritic Variant in Two Female Patients.
![]() |
Related Articles |
Epidermolysis Bullosa Pruriginosa Excoriée: A Deceptive Pruritic Variant in Two Female Patients.
Acta Derm Venereol. 2015 Jun 3;
Authors: Gostyńska KB, Jonkman MF
Abstract
is missing (Short communication).
PMID: 26039182 [PubMed – as supplied by publisher]
Posted in Acta Derm Venereol
Comments Off on Epidermolysis Bullosa Pruriginosa Excoriée: A Deceptive Pruritic Variant in Two Female Patients.